Skip to main content

Very Rare Malignant Tumors Program News

Your child will be cared for by world leaders in rare childhood cancers. We provide medical care, emotional counseling and much more. We make sure your child and every member of your family get the highest level of support.

Existing patients or family members
New patients, referrals and second opinions

Q&A with Joshua Eisenberg, MD

Aug 9, 2022

Get to know Dr. Joshua Eisenberg, our newest attending physician in the Division of Gastroenterology, Hepatology and Nutrition.

FDA Approves Drug for Rare Cancer

Jul 25, 2022

CHOP played an instrumental role in leading one of two clinical trials that led to the approval of Xalkori® for unresectable, recurrent, or refractory ALK-positive IMT.

Jump back to top